Mitral Transcatheter Edge‐to‐Edge Repair in Symptomatic Hypertrophic Cardiomyopathy: A Systematic Review
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.70132 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Ashraf Ahmed und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Yale University School of Medicine, Bridgeport Hospital, Bridgeport, Connecticut, USA. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Cardiac Catheterization, Ventricular Outflow Obstruction, Mitral Valve Insufficiency. Die Arbeit nennt 29 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
Hypertrophic cardiomyopathy (HCM) with left ventricular outflow tract (LVOT) obstruction poses significant clinical challenges. Although septal reduction therapy (SRT) is the first treatment strategy after medical therapy, mitral transcatheter edge‐to‐edge repair (M‐TEER) has been reported in the emerging literature to alleviate the LVOT obstruction related to mitral regurgitation (MR) and systolic anterior motion (SAM).
Aims
In this article, we aim to evaluate the efficacy and safety of M‐TEER in managing symptomatic HCM.
Methods
We conducted a systematic review according to Cochrane Handbook and the PRISMA statement. We comprehensively searched Embase, PubMed, and Scopus from inception to September 5, 2024, to identify case reports where symptomatic HCM were managed by M‐TEER. The data extracted included patient demographics, procedural details, hemodynamics, and outcomes.
Results
We identified 20 patients in the literature with symptomatic HCM who underwent M‐TEER. The average age was 73.06 ± 13.81 years, predominantly male, 60%. All patients had evidence of intermittent LVOT obstruction, MR, and SAM. NYHA III−IV was the presenting symptom in 95% of the patients. M‐TEER was performed in all patients, resulting in a significant improvement in the LVOT gradient from 68.9 ± 34.4 to 12.35 ± 9.6 mmHg, an average improvement in MR grade of 2.68, and a mean improvement in NYHA class of two. Nineteen patients had successful procedures, underscoring the potential of M‐TEER in treating symptomatic HCM, while one patient succumbed to cardiogenic shock.
Conclusion
M‐TEER appears to be viable and safe for managing symptomatic HCM due to LVOT obstruction secondary to MR and SAM in patients where SRT is deemed unsuitable. However, more evidence in a larger scale is required to demonstrate its long‐term efficacy and outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Yale University School of Medicine, Bridgeport Hospital, Bridgeport, Connecticut, USA.
- Department of Cardiovascular Medicine, University of Miami, Coral Gables, Florida, USA.
- Department of Internal Medicine, UMKC University, Kansas City, Missouri, USA.
- Department Cardiovascular Diseases, Yale University School of Medicine, Bridgeport Hospital, Bridgeport, Connecticut, USA.
- Department Interventional Cardiology, University of Miami, Coral Gables, Florida, USA.
ORCID-Profile: Ashraf Ahmed, Muath Baniowda
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Ahmed, A., Webber, F., Perumalla, H. S., Abid, S., Baniowda, M., Arango, J., & Dyal, M. D. (2025). Mitral Transcatheter Edge‐to‐Edge Repair in Symptomatic Hypertrophic Cardiomyopathy: A Systematic Review. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70132
Vancouver
Ahmed A, Webber F, Perumalla HS, Abid S, Baniowda M, Arango J, et al. Mitral Transcatheter Edge‐to‐Edge Repair in Symptomatic Hypertrophic Cardiomyopathy: A Systematic Review. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70132
BibTeX
@article{Ahmed2025,
author = {Ahmed, Ashraf and Webber, Fabricio and Perumalla, Hima Sanjana and Abid, Shaun and Baniowda, Muath and Arango, Juan and Dyal, Michael David},
title = {Mitral Transcatheter Edge‐to‐Edge Repair in Symptomatic Hypertrophic Cardiomyopathy: A Systematic Review},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.70132}
}
EUVIMED